(Q44244021)

1 December 2017

title

An integrated analysis of germline and somatic, genetic and epigenetic alterations at 9p21.3 in glioblastoma (English)

1 reference

1 December 2017

9

Jianfeng Xu

1 reference

1 December 2017

Junjie Feng

1

1 reference

1 December 2017

Seong-Tae Kim

2

1 reference

1 December 2017

Wennuan Liu

3

1 reference

1 December 2017

Jin Woo Kim

4

1 reference

1 December 2017

Zheng Zhang

5

1 reference

1 December 2017

Yi Zhu

6

1 reference

1 December 2017

Michael Berens

7

1 reference

1 December 2017

Jielin Sun

8

1 reference

1 December 2017

language of work or name

English

0 references

publication date

28 June 2011

1 reference

1 December 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Cancer

1 reference

1 December 2017

volume

118

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

232-240

1 reference

Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26250

INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26250

The Arf/p53 pathway in cancer and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26250

A cell cycle regulator potentially involved in genesis of many tumor types

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26250

Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26250

Genome-wide association study identifies five susceptibility loci for glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26250

Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26250

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26250

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26250

Prognostic molecular markers with no impact on decision-making: the paradox of gliomas based on a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26250

p16(INK4a) translation suppressed by miR-24

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26250

Micro RNA-125b (miRNA-125b) function in astrogliosis and glial cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26250

Extensive modulation of a set of microRNAs in primary glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26250

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26250

Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-beta-mediated induction of the CDK inhibitor p15(Ink4B)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26250

Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26250

p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26250

21 January 2018

Identifiers

DOI

10.1002/CNCR.26250

1 reference

1 December 2017

1 reference